Abstract The International Agency for Research on Cancer of the World Health Organization
predicts that there will be∼ 13–17 million cancer-related deaths each year worldwide by …

Cancer remains one of the leading causes of death in most regions of the world, including
the United States (Beardsley 1994). According to the American Cancer Society (ACS 2007) …

Millions of people suffer from cancer worldwide, and many cases end up with the death of
the patient. The current procedures for cancer diagnosis and therapy suffer from several …

There is urgency for the development of nanomaterials that can meet emerging biomedical
needs. Magnetic nanoparticles (MNPs) offer high magnetic moments and surface‐area‐to …

Paramagnetic nanoparticles have many applications for cancer diagnosis and therapy. More
importantly, advances in nanoparticle engineering enable performance enhancements over …

The past two decades have seen a surge in the development and application of
nanoparticles for biomedical uses, with a focused effort on engineering particles for …

The metastasis of cancer epitomizes the diagnostic and therapeutic challenge as a result of
cancer heterogeneity. To overcome the uncontrolled growth of the proliferating cells …

In recent years, extensive studies in the field of nanomedicine have been focused on
alternatives to conventional cancer treatments. Nanoparticles, due to their size and the …

Over the past few years, engineered inorganic nanoparticles have been studied,
researched, and applied extensively in the biomedical field because resultant platforms …

Cancer is currently a leading cause of death worldwide. The World Health Organization
estimates an increase of 60% in the global cancer incidence in the next two decades. The …